Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Immunoterapialääkkeen pembrolitsumabin lisäämisen testaus tavanomaiseen kemoterapiahoitoon (paklitakseli ja karboplatiini) vaiheen III-IV tai uusiutuvan kohdun limakalvon syövän hoidossa

keskiviikko 11. marraskuuta 2026 päivittänyt: National Cancer Institute (NCI)

Vaiheen III satunnaistettu, lumekontrolloitu tutkimus pembrolitsumabista (MK-3475, NSC #776864) paklitakselin ja karboplatiinin lisäksi mitattavissa olevan III- tai IVA-vaiheen, IVB-vaiheen tai uusiutuvan kohdun limakalvon syövän hoidossa

This phase III trial studies how well the combination of pembrolizumab, paclitaxel and carboplatin works compared with paclitaxel and carboplatin alone in treating patients with endometrial cancer that is stage III or IV, or has come back after a period of improvement (recurrent). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Paclitaxel and carboplatin are chemotherapy drugs used as part of the usual treatment approach for this type of cancer. This study aims to assess if adding immunotherapy to these drugs is better or worse than the usual approach for treatment of this cancer.

Tutkimuksen yleiskatsaus

Yksityiskohtainen kuvaus

PRIMARY OBJECTIVE:

I. To evaluate the efficacy of pembrolizumab (MK-3475) in combination with paclitaxel and carboplatin in patients with advanced stage (measurable stage III or IVA), stage IVB and recurrent endometrial cancer.

SECONDARY OBJECTIVES:

I. To determine the nature, frequency and degree of toxicity as assessed by Common Terminology Criteria for Adverse Events (CTCAE) for each treatment arm.

II. To evaluate blinded independent central review (BICR) assessed or investigator assessed objective response rate (ORR) as assessed by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 by treatment arm and by mismatch repair (MMR) immunohistochemistry (IHC) status in patients who enter the study with measurable disease.

III. To evaluate BICR assessed or investigator assessed duration of response (DOR) by treatment arm and by MMR IHC status in patients who enter the study with measurable disease.

IV. To evaluate the effect of pembrolizumab (MK-3475) on overall survival (OS) in patients with mismatch repair protein proficient (pMMR) or mismatch repair deficiency (dMMR).

V. To determine whether the addition of pembrolizumab (MK-3475) to standard combination chemotherapy is associated with improved patient reported physical function as measured with the Patient-Reported Outcomes Measurement Information System (PROMIS)-physical function scale (short form), quality of life as measured with the Functional Assessment of Cancer Therapy (FACT) - Endometrial Trial Outcome Index (En TOI) and worsened fatigue as measured with the PROMIS-Fatigue scale (short form) in the pMMR patients.

VI. To determine concordance between institutional MMR IHC testing and centralized MMR IHC.

EXPLORATORY OBJECTIVES:

I. To explore the correlation between patient-reported physical function as measured with the PROMIS-physical function scale (short form) and quality of life as measure with the FACT-En TOI.

II. To explore whether the addition of pembrolizumab (MK-3475) to standard combination chemotherapy is associated with self-reported neurotoxicity as measured with the FACT/Gynecologic Oncology Group Neurotoxicity (GOG-Ntx) subscale (short) and the extent to which patients differ on their self-reported bother from side effects of cancer therapy in the pMMR patients.

III. To evaluate the efficacy of pembrolizumab (MK-3475) in combination with paclitaxel and carboplatin in patients with advanced stage (measurable stage III or IVA), stage IVB and recurrent endometrial cancer by Programmed Death Ligand 1 (PD-L1) IHC (positive versus [vs] negative).

IV. To assess the association between PD-L1 IHC (positive vs negative) and mismatch repair status (pMMR and dMMR).

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I:

COMBINATION PHASE: Patients receive placebo intravenously (IV) over 30 minutes on day 1 of each cycle, paclitaxel IV over 3 hours on day 1 of each cycle, and carboplatin IV over 30-60 minutes on day 1 of each cycle. Treatment repeats every 3 weeks for 6 cycles in the absence of disease progression or unacceptable toxicity. Patients with stable disease (SD) or partial response (PR) who still have measurable disease may continue treatment for up to a total 10 cycles (if deemed necessary by the treating physician) in the absence of disease progression or unacceptable toxicity.

MAINTENANCE PHASE: Patients receive placebo IV over 30 minutes on day 1 of each cycle. Treatment repeats every 6 weeks for up to 14 cycles in the absence of disease progression or unacceptable toxicity.

On February 6, 2023, all patient treatment assignments were unblinded. Patients randomized to Arm I will not receive additional placebo infusions.

ARM II:

COMBINATION PHASE: Patients receive pembrolizumab IV over 30 minutes on day 1 of each cycle, paclitaxel IV over 3 hours on day 1 of each cycle, and carboplatin IV over 30-60 minutes on day 1 of each cycle. Treatment repeats every 3 weeks for 6 cycles in the absence of disease progression or unacceptable toxicity. Patients with SD or PR who still have measurable disease may continue treatment for up to a total of 10 cycles (if deemed necessary by the treating physician) in the absence of disease progression or unacceptable toxicity.

MAINTENANCE PHASE: Patients receive pembrolizumab IV over 30 minutes on day 1 of each cycle. Treatment repeats every 6 weeks for up to 14 cycles in the absence of disease progression or unacceptable toxicity.

Patients undergo computed tomography (CT) scan throughout the study.

After completion of study treatment, patients are followed up every 3 months for 2 years and then every 6 months for 3 years.

Opintotyyppi

Interventio

Ilmoittautuminen (Todellinen)

813

Vaihe

  • Vaihe 3

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskelupaikat

      • Daegu, Etelä -Korea, 41404
        • Kyungpook National University Chilgok Hospital
      • Seoul, Etelä -Korea, 05505
        • Asan Medical Center
      • Seoul, Etelä -Korea, 06273
        • Gangnam Severance Hospital
      • Seoul, Etelä -Korea, 120-752
        • Yonsei University Health System-Severance Hospital
      • Seoul, Etelä -Korea, 139-706
        • Korea Cancer Center Hospital
    • Daegu
      • Dalseo-gu, Daegu, Etelä -Korea, 42601
        • Keimyung University-Dongsan Medical Center
    • Gyeongsangnam-do
      • Seoul, Gyeongsangnam-do, Etelä -Korea, 51353
        • Samsung Changwon Hospital
    • Kyeonggi-do
      • Seongnam, Kyeonggi-do, Etelä -Korea, 463-707
        • Seoul National University Bundang Hospital
      • Saitama, Japani, 350-1298
        • Saitama Medical University International Medical Center
    • Ehime
      • Tōon, Ehime, Japani, 791-0295
        • Ehime University Hospital
    • Hiroshima
      • Kure, Hiroshima, Japani, 737
        • Kure Medical Center and Chugoku Cancer Center
    • Niigata
      • Niigata, Niigata, Japani, 951-8520
        • Niigata University Medical and Dental Hospital
    • New Brunswick
      • Moncton, New Brunswick, Kanada, E1C 6Z8
        • The Moncton Hospital
    • Ontario
      • Barrie, Ontario, Kanada, L4M 6M2
        • Royal Victoria Regional Health Centre
      • Greater Sudbury, Ontario, Kanada, P3E 5J1
        • Health Sciences North
      • Hamilton, Ontario, Kanada, L8V 5C2
        • Juravinski Cancer Centre at Hamilton Health Sciences
      • Kingston, Ontario, Kanada, K7L 2V7
        • Kingston Health Sciences Centre
      • London, Ontario, Kanada, N6A 4L6
        • London Regional Cancer Program
      • Oshawa, Ontario, Kanada, L1G 2B9
        • Lakeridge Health Oshawa
      • Sault Ste. Marie, Ontario, Kanada, P6B 0A8
        • Algoma District Cancer Program Sault Area Hospital
      • Toronto, Ontario, Kanada, M5G 2M9
        • University Health Network-Princess Margaret Hospital
      • Toronto, Ontario, Kanada, M4N 3M5
        • Odette Cancer Centre- Sunnybrook Health Sciences Centre
    • Quebec
      • Laval, Quebec, Kanada, H7M 3L9
        • Hopital de la Cite-de-la-Sante
      • Montreal, Quebec, Kanada, H2X 3E4
        • CHUM - Centre Hospitalier de l'Universite de Montreal
    • Saskatchewan
      • Regina, Saskatchewan, Kanada, S4T 7T1
        • Allan Blair Cancer Centre
      • Saskatoon, Saskatchewan, Kanada, S7N 4H4
        • Saskatoon Cancer Centre
      • San Juan, Puerto Rico, 00927
        • Centro Comprensivo de Cancer de UPR
    • Alabama
      • Birmingham, Alabama, Yhdysvallat, 35233
        • University of Alabama at Birmingham Cancer Center
    • Alaska
      • Anchorage, Alaska, Yhdysvallat, 99508
        • Alaska Women's Cancer Care
    • Arizona
      • Goodyear, Arizona, Yhdysvallat, 85338
        • CTCA at Western Regional Medical Center
    • Arkansas
      • Jonesboro, Arkansas, Yhdysvallat, 72401
        • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
      • Little Rock, Arkansas, Yhdysvallat, 72205
        • University of Arkansas for Medical Sciences
    • California
      • Baldwin Park, California, Yhdysvallat, 91706
        • Kaiser Permanente-Baldwin Park
      • Bellflower, California, Yhdysvallat, 90706
        • Kaiser Permanente-Bellflower
      • Berkeley, California, Yhdysvallat, 94704
        • Alta Bates Summit Medical Center-Herrick Campus
      • Clovis, California, Yhdysvallat, 93611
        • Community Cancer Institute
      • Duarte, California, Yhdysvallat, 91010
        • City of Hope Comprehensive Cancer Center
      • Harbor City, California, Yhdysvallat, 90710
        • Kaiser Permanente South Bay
      • Irvine, California, Yhdysvallat, 92618
        • Kaiser Permanente-Irvine
      • La Jolla, California, Yhdysvallat, 92093
        • UC San Diego Moores Cancer Center
      • Lancaster, California, Yhdysvallat, 93534
        • City of Hope Antelope Valley
      • Los Angeles, California, Yhdysvallat, 90033
        • USC / Norris Comprehensive Cancer Center
      • Los Angeles, California, Yhdysvallat, 90048
        • Cedars-Sinai Medical Center
      • Los Angeles, California, Yhdysvallat, 90095
        • UCLA / Jonsson Comprehensive Cancer Center
      • Los Angeles, California, Yhdysvallat, 90027
        • Kaiser Permanente Los Angeles Medical Center
      • Los Angeles, California, Yhdysvallat, 90033
        • Los Angeles General Medical Center
      • Mountain View, California, Yhdysvallat, 94040
        • Palo Alto Medical Foundation-Gynecologic Oncology
      • Oakland, California, Yhdysvallat, 94611
        • Kaiser Permanente-Oakland
      • Orange, California, Yhdysvallat, 92868
        • UC Irvine Health/Chao Family Comprehensive Cancer Center
      • Orange, California, Yhdysvallat, 92868
        • Saint Joseph Hospital - Orange
      • Rancho Mirage, California, Yhdysvallat, 92270
        • Eisenhower Medical Center
      • Redding, California, Yhdysvallat, 96001
        • Mercy Regional Cancer Center
      • Redding, California, Yhdysvallat, 96002
        • Mercy Oncology Center
      • Riverside, California, Yhdysvallat, 92505
        • Kaiser Permanente-Riverside
      • Roseville, California, Yhdysvallat, 95661
        • Kaiser Permanente-Roseville
      • Sacramento, California, Yhdysvallat, 95817
        • University of California Davis Comprehensive Cancer Center
      • Sacramento, California, Yhdysvallat, 95814
        • Kaiser Permanente Downtown Commons
      • Sacramento, California, Yhdysvallat, 95816
        • Mercy Cancer Center - Sacramento
      • San Diego, California, Yhdysvallat, 92120
        • Kaiser Permanente-San Diego Zion
      • San Diego, California, Yhdysvallat, 92134
        • Naval Medical Center -San Diego
      • San Francisco, California, Yhdysvallat, 94115
        • Kaiser Permanente-San Francisco
      • San Francisco, California, Yhdysvallat, 94158
        • UCSF Medical Center-Mission Bay
      • San Francisco, California, Yhdysvallat, 94115
        • California Pacific Medical Center-Pacific Campus
      • San Francisco, California, Yhdysvallat, 94110
        • Zuckerberg San Francisco General Hospital
      • San Jose, California, Yhdysvallat, 95119
        • Kaiser Permanente-Santa Teresa-San Jose
      • San Leandro, California, Yhdysvallat, 94577
        • Kaiser Permanente San Leandro
      • San Marcos, California, Yhdysvallat, 92078
        • Kaiser Permanente-San Marcos
      • Santa Clara, California, Yhdysvallat, 95051
        • Kaiser Permanente Medical Center - Santa Clara
      • South Pasadena, California, Yhdysvallat, 91030
        • City of Hope South Pasadena
      • South San Francisco, California, Yhdysvallat, 94080
        • Kaiser Permanente-South San Francisco
      • Sunnyvale, California, Yhdysvallat, 94086
        • Palo Alto Medical Foundation-Sunnyvale
      • Upland, California, Yhdysvallat, 91786
        • City of Hope Upland
      • Vallejo, California, Yhdysvallat, 94589
        • Kaiser Permanente-Vallejo
      • Walnut Creek, California, Yhdysvallat, 94596
        • Kaiser Permanente-Walnut Creek
      • Walnut Creek, California, Yhdysvallat, 94598
        • John Muir Medical Center-Walnut Creek
    • Colorado
      • Colorado Springs, Colorado, Yhdysvallat, 80907
        • Penrose-Saint Francis Healthcare
      • Colorado Springs, Colorado, Yhdysvallat, 80909
        • UCHealth Memorial Hospital Central
      • Colorado Springs, Colorado, Yhdysvallat, 80920
        • Memorial Hospital North
      • Fort Collins, Colorado, Yhdysvallat, 80524
        • Poudre Valley Hospital
      • Fort Collins, Colorado, Yhdysvallat, 80528
        • Cancer Care and Hematology-Fort Collins
      • Greeley, Colorado, Yhdysvallat, 80631
        • UCHealth Greeley Hospital
      • Greeley, Colorado, Yhdysvallat, 80631
        • Banner North Colorado Medical Center
      • Loveland, Colorado, Yhdysvallat, 80538
        • Medical Center of the Rockies
      • Loveland, Colorado, Yhdysvallat, 80539
        • Banner North Colorado Medical Center - Loveland Campus
    • Connecticut
      • Danbury, Connecticut, Yhdysvallat, 06810
        • Danbury Hospital
      • Guilford, Connecticut, Yhdysvallat, 06437
        • Smilow Cancer Hospital Care Center - Guilford
      • Hartford, Connecticut, Yhdysvallat, 06105
        • Smilow Cancer Hospital Care Center at Saint Francis
      • Hartford, Connecticut, Yhdysvallat, 06102
        • Hartford Hospital
      • New Britain, Connecticut, Yhdysvallat, 06050
        • The Hospital of Central Connecticut
      • New Haven, Connecticut, Yhdysvallat, 06520
        • Yale University
      • North Haven, Connecticut, Yhdysvallat, 06473
        • Yale-New Haven Hospital North Haven Medical Center
      • Norwalk, Connecticut, Yhdysvallat, 06856
        • Norwalk Hospital
      • Stamford, Connecticut, Yhdysvallat, 06904
        • Stamford Hospital/Bennett Cancer Center
      • Torrington, Connecticut, Yhdysvallat, 06790
        • Smilow Cancer Hospital-Torrington Care Center
      • Trumbull, Connecticut, Yhdysvallat, 06611
        • Smilow Cancer Hospital Care Center-Trumbull
      • Waterbury, Connecticut, Yhdysvallat, 06708
        • Smilow Cancer Hospital-Waterbury Care Center
      • Waterford, Connecticut, Yhdysvallat, 06385
        • Smilow Cancer Hospital Care Center - Waterford
    • Delaware
      • Newark, Delaware, Yhdysvallat, 19713
        • Helen F Graham Cancer Center
    • District of Columbia
      • Washington D.C., District of Columbia, Yhdysvallat, 20010
        • MedStar Washington Hospital Center
      • Washington D.C., District of Columbia, Yhdysvallat, 20016
        • Sibley Memorial Hospital
    • Florida
      • Bradenton, Florida, Yhdysvallat, 34205
        • Florida Cancer Specialists - Bradenton Cancer Center
      • Sarasota, Florida, Yhdysvallat, 34239
        • Sarasota Memorial Hospital
      • Sarasota, Florida, Yhdysvallat, 34232
        • Florida Cancer Specialists - Sarasota
      • Sarasota, Florida, Yhdysvallat, 34239
        • Florida Cancer Specialists - Sarasota Downtown
      • Venice, Florida, Yhdysvallat, 34285
        • Florida Cancer Specialists - Venice Island
      • Venice, Florida, Yhdysvallat, 34275
        • Florida Cancer Specialists - Venice Pinebrook
    • Georgia
      • Atlanta, Georgia, Yhdysvallat, 30308
        • Emory University Hospital Midtown
      • Atlanta, Georgia, Yhdysvallat, 30322
        • Emory University Hospital/Winship Cancer Institute
      • Atlanta, Georgia, Yhdysvallat, 30342
        • Emory Saint Joseph's Hospital
      • Atlanta, Georgia, Yhdysvallat, 30303
        • Grady Health System
      • Atlanta, Georgia, Yhdysvallat, 30342
        • Northside Hospital
      • Austell, Georgia, Yhdysvallat, 30106
        • WellStar Cobb Hospital
      • Fayetteville, Georgia, Yhdysvallat, 30214
        • Piedmont Fayette Hospital
      • Gainesville, Georgia, Yhdysvallat, 30501
        • Northeast Georgia Medical Center-Gainesville
      • Marietta, Georgia, Yhdysvallat, 30060
        • Wellstar Kennestone Hospital
      • Marietta, Georgia, Yhdysvallat, 30060
        • WellStar Health System Inc
      • Newnan, Georgia, Yhdysvallat, 30265
        • CTCA at Southeastern Regional Medical Center
      • Roswell, Georgia, Yhdysvallat, 30076
        • WellStar North Fulton Hospital
      • Savannah, Georgia, Yhdysvallat, 31405
        • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
      • Savannah, Georgia, Yhdysvallat, 31404
        • Memorial Health University Medical Center
      • Smyrna, Georgia, Yhdysvallat, 30080
        • WellStar Vinings Health Park
    • Hawaii
      • Honolulu, Hawaii, Yhdysvallat, 96813
        • Queen's Medical Center
      • Honolulu, Hawaii, Yhdysvallat, 96826
        • Kapiolani Medical Center for Women and Children
    • Idaho
      • Boise, Idaho, Yhdysvallat, 83706
        • Saint Alphonsus Cancer Care Center-Boise
      • Boise, Idaho, Yhdysvallat, 83712
        • Saint Luke's Cancer Institute - Boise
      • Caldwell, Idaho, Yhdysvallat, 83605
        • Saint Alphonsus Cancer Care Center-Caldwell
      • Fruitland, Idaho, Yhdysvallat, 83619
        • Saint Luke's Cancer Institute - Fruitland
      • Meridian, Idaho, Yhdysvallat, 83642
        • Saint Luke's Cancer Institute - Meridian
      • Nampa, Idaho, Yhdysvallat, 83687
        • Saint Alphonsus Cancer Care Center-Nampa
      • Nampa, Idaho, Yhdysvallat, 83687
        • Saint Luke's Cancer Institute - Nampa
      • Twin Falls, Idaho, Yhdysvallat, 83301
        • Saint Luke's Cancer Institute - Twin Falls
    • Illinois
      • Chicago, Illinois, Yhdysvallat, 60611
        • Northwestern University
      • Chicago, Illinois, Yhdysvallat, 60637
        • University of Chicago Comprehensive Cancer Center
      • Chicago, Illinois, Yhdysvallat, 60612
        • University of Illinois
      • Chicago, Illinois, Yhdysvallat, 60612
        • Rush MD Anderson Cancer Center
      • Danville, Illinois, Yhdysvallat, 61832
        • Carle at The Riverfront
      • Decatur, Illinois, Yhdysvallat, 62526
        • Cancer Care Specialists of Illinois - Decatur
      • Effingham, Illinois, Yhdysvallat, 62401
        • Crossroads Cancer Center
      • Evanston, Illinois, Yhdysvallat, 60201
        • NorthShore University HealthSystem-Evanston Hospital
      • Geneva, Illinois, Yhdysvallat, 60134
        • Northwestern Medicine Cancer Center Delnor
      • Glenview, Illinois, Yhdysvallat, 60026
        • NorthShore University HealthSystem-Glenbrook Hospital
      • Harvey, Illinois, Yhdysvallat, 60426
        • Ingalls Memorial Hospital
      • Highland Park, Illinois, Yhdysvallat, 60035
        • NorthShore University HealthSystem-Highland Park Hospital
      • Mattoon, Illinois, Yhdysvallat, 61938
        • Carle Physician Group-Mattoon/Charleston
      • Maywood, Illinois, Yhdysvallat, 60153
        • Loyola University Medical Center
      • New Lenox, Illinois, Yhdysvallat, 60451
        • UC Comprehensive Cancer Center at Silver Cross
      • O'Fallon, Illinois, Yhdysvallat, 62269
        • Cancer Care Center of O'Fallon
      • Orland Park, Illinois, Yhdysvallat, 60462
        • University of Chicago Medicine-Orland Park
      • Springfield, Illinois, Yhdysvallat, 62702
        • Springfield Clinic
      • Urbana, Illinois, Yhdysvallat, 61801
        • Carle Cancer Center
      • Warrenville, Illinois, Yhdysvallat, 60555
        • Northwestern Medicine Cancer Center Warrenville
      • Zion, Illinois, Yhdysvallat, 60099
        • Midwestern Regional Medical Center
    • Indiana
      • Crown Point, Indiana, Yhdysvallat, 46307
        • Northwest Cancer Center - Crown Point
      • Dyer, Indiana, Yhdysvallat, 46311
        • Northwest Oncology LLC
      • Hobart, Indiana, Yhdysvallat, 46342
        • Northwest Cancer Center - Hobart
      • Hobart, Indiana, Yhdysvallat, 46342
        • Saint Mary Medical Center
      • Indianapolis, Indiana, Yhdysvallat, 46237
        • Franciscan Health Indianapolis
      • Indianapolis, Indiana, Yhdysvallat, 46202
        • Indiana University/Melvin and Bren Simon Cancer Center
      • Indianapolis, Indiana, Yhdysvallat, 46219
        • Community Cancer Center East
      • Indianapolis, Indiana, Yhdysvallat, 46227
        • Community Cancer Center South
      • Indianapolis, Indiana, Yhdysvallat, 46256
        • Community Cancer Center North
      • Indianapolis, Indiana, Yhdysvallat, 46260
        • Ascension Saint Vincent Indianapolis Hospital
      • Indianapolis, Indiana, Yhdysvallat, 46312
        • Saint Catherine Hospital
      • Mooresville, Indiana, Yhdysvallat, 46158
        • Franciscan Health Mooresville
      • Munster, Indiana, Yhdysvallat, 46321
        • The Community Hospital
      • Munster, Indiana, Yhdysvallat, 46321
        • Women's Diagnostic Center - Munster
      • Valparaiso, Indiana, Yhdysvallat, 46383
        • Northwest Cancer Center - Valparaiso
    • Iowa
      • Iowa City, Iowa, Yhdysvallat, 52242
        • University of Iowa/Holden Comprehensive Cancer Center
    • Kansas
      • Fairway, Kansas, Yhdysvallat, 66205
        • University of Kansas Clinical Research Center
      • Kansas City, Kansas, Yhdysvallat, 66160
        • University of Kansas Cancer Center
      • Overland Park, Kansas, Yhdysvallat, 66211
        • University of Kansas Hospital-Indian Creek Campus
      • Westwood, Kansas, Yhdysvallat, 66205
        • University of Kansas Hospital-Westwood Cancer Center
    • Kentucky
      • Edgewood, Kentucky, Yhdysvallat, 41017
        • Saint Elizabeth Healthcare Edgewood
    • Louisiana
      • Baton Rouge, Louisiana, Yhdysvallat, 70805
        • LSU Health Baton Rouge-North Clinic
      • Baton Rouge, Louisiana, Yhdysvallat, 70808
        • Our Lady of The Lake
      • Baton Rouge, Louisiana, Yhdysvallat, 70817
        • Woman's Hospital
      • Baton Rouge, Louisiana, Yhdysvallat, 70817
        • Our Lady of the Lake Medical Oncology
      • Baton Rouge, Louisiana, Yhdysvallat, 70808
        • Our Lady of the Lake Physician Group
      • Metairie, Louisiana, Yhdysvallat, 70006
        • East Jefferson General Hospital
      • New Orleans, Louisiana, Yhdysvallat, 70121
        • Ochsner Medical Center Jefferson
      • New Orleans, Louisiana, Yhdysvallat, 70112
        • University Medical Center New Orleans
      • New Orleans, Louisiana, Yhdysvallat, 70115
        • Ochsner Baptist Medical Center
    • Maine
      • Augusta, Maine, Yhdysvallat, 04330
        • Harold Alfond Center for Cancer Care
      • Belfast, Maine, Yhdysvallat, 04915
        • MaineHealth Waldo Hospital
      • Biddeford, Maine, Yhdysvallat, 04005
        • MaineHealth Maine Medical Center - Biddeford
      • Brewer, Maine, Yhdysvallat, 04412
        • Lafayette Family Cancer Center-EMMC
      • Rockport, Maine, Yhdysvallat, 04856
        • Penobscot Bay Medical Center
      • Sanford, Maine, Yhdysvallat, 04073
        • MaineHealth Cancer Care and IV Therapy - Sanford
      • Scarborough, Maine, Yhdysvallat, 04074
        • MaineHealth Maine Medical Center- Scarborough
    • Maryland
      • Annapolis, Maryland, Yhdysvallat, 21401
        • Luminis Health Anne Arundel Medical Center
      • Baltimore, Maryland, Yhdysvallat, 21237
        • MedStar Franklin Square Medical Center/Weinberg Cancer Institute
      • Baltimore, Maryland, Yhdysvallat, 21287
        • Johns Hopkins University/Sidney Kimmel Cancer Center
      • Baltimore, Maryland, Yhdysvallat, 21215
        • Sinai Hospital of Baltimore
      • Baltimore, Maryland, Yhdysvallat, 21204
        • Greater Baltimore Medical Center
      • Baltimore, Maryland, Yhdysvallat, 21201
        • University of Maryland/Greenebaum Cancer Center
      • Baltimore, Maryland, Yhdysvallat, 21229
        • Saint Agnes Hospital
      • Bel Air, Maryland, Yhdysvallat, 21014
        • UM Upper Chesapeake Medical Center
      • Bethesda, Maryland, Yhdysvallat, 20889-5600
        • Walter Reed National Military Medical Center
      • Easton, Maryland, Yhdysvallat, 21601
        • University of Maryland Shore Medical Center at Easton
    • Massachusetts
      • Burlington, Massachusetts, Yhdysvallat, 01805
        • Lahey Clinic
      • Lowell, Massachusetts, Yhdysvallat, 01854
        • Lowell General Hospital
      • Springfield, Massachusetts, Yhdysvallat, 01199
        • Baystate Medical Center
      • Winchester, Massachusetts, Yhdysvallat, 01890
        • Beth Israel Deaconess Medical Center/Winchester Center for Cancer Care
      • Worcester, Massachusetts, Yhdysvallat, 01605
        • UMass Memorial Medical Center - Memorial Division
    • Michigan
      • Ann Arbor, Michigan, Yhdysvallat, 48109
        • University of Michigan Rogel Cancer Center
      • Ann Arbor, Michigan, Yhdysvallat, 48106
        • Trinity Health Saint Joseph Mercy Hospital Ann Arbor
      • Flint, Michigan, Yhdysvallat, 48503
        • Genesee Hematology Oncology PC
      • Flint, Michigan, Yhdysvallat, 48503
        • Genesys Hurley Cancer Institute
      • Flint, Michigan, Yhdysvallat, 48503
        • Cancer Hematology Centers - Flint
      • Grand Rapids, Michigan, Yhdysvallat, 49503
        • Corewell Health Grand Rapids Hospitals - Butterworth Hospital
      • Kalamazoo, Michigan, Yhdysvallat, 49007
        • West Michigan Cancer Center
      • Kalamazoo, Michigan, Yhdysvallat, 49007
        • Bronson Methodist Hospital
      • Lansing, Michigan, Yhdysvallat, 48912
        • University of Michigan Health - Sparrow Lansing
      • Traverse City, Michigan, Yhdysvallat, 49684
        • Munson Medical Center
    • Minnesota
      • Bemidji, Minnesota, Yhdysvallat, 56601
        • Sanford Joe Lueken Cancer Center
      • Duluth, Minnesota, Yhdysvallat, 55805
        • Essentia Health Cancer Center
      • Rochester, Minnesota, Yhdysvallat, 55905
        • Mayo Clinic in Rochester
    • Mississippi
      • Jackson, Mississippi, Yhdysvallat, 39216
        • University of Mississippi Medical Center
      • Jackson, Mississippi, Yhdysvallat, 39202
        • Mississippi Baptist Medical Center
    • Missouri
      • Kansas City, Missouri, Yhdysvallat, 64111
        • Saint Luke's Hospital of Kansas City
      • Springfield, Missouri, Yhdysvallat, 65804
        • Mercy Hospital Springfield
      • St Louis, Missouri, Yhdysvallat, 63110
        • Washington University School of Medicine
      • St Louis, Missouri, Yhdysvallat, 63141
        • Mercy Hospital Saint Louis
    • Montana
      • Anaconda, Montana, Yhdysvallat, 59711
        • Community Hospital of Anaconda
      • Billings, Montana, Yhdysvallat, 59101
        • Billings Clinic Cancer Center
    • Nebraska
      • Grand Island, Nebraska, Yhdysvallat, 68803
        • Nebraska Cancer Specialists/Oncology Hematology West PC
      • Omaha, Nebraska, Yhdysvallat, 68114
        • Nebraska Methodist Hospital
      • Omaha, Nebraska, Yhdysvallat, 68198
        • University of Nebraska Medical Center
    • New Hampshire
      • Lebanon, New Hampshire, Yhdysvallat, 03756
        • Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
    • New Jersey
      • Basking Ridge, New Jersey, Yhdysvallat, 07920
        • Memorial Sloan Kettering Basking Ridge
      • Camden, New Jersey, Yhdysvallat, 08103
        • Cooper Hospital University Medical Center
      • Lakewood, New Jersey, Yhdysvallat, 08701
        • Monmouth Medical Center Southern Campus
      • Livingston, New Jersey, Yhdysvallat, 07039
        • Cooperman Barnabas Medical Center
      • Long Branch, New Jersey, Yhdysvallat, 07740
        • Monmouth Medical Center
      • Middletown, New Jersey, Yhdysvallat, 07748
        • Memorial Sloan Kettering Monmouth
      • Montvale, New Jersey, Yhdysvallat, 07645
        • Memorial Sloan Kettering Bergen
      • Neptune City, New Jersey, Yhdysvallat, 07753
        • Jersey Shore Medical Center
      • New Brunswick, New Jersey, Yhdysvallat, 08903
        • Rutgers Cancer Institute of New Jersey
      • Paramus, New Jersey, Yhdysvallat, 07652
        • The Valley Hospital - Luckow Pavilion
      • Ridgewood, New Jersey, Yhdysvallat, 07450
        • Neurosurgeons of New Jersey-Ridgewood
      • Ridgewood, New Jersey, Yhdysvallat, 07450
        • Valley Health System Ridgewood Campus
      • Somerville, New Jersey, Yhdysvallat, 08876
        • Robert Wood Johnson University Hospital Somerset
      • Toms River, New Jersey, Yhdysvallat, 08755
        • Community Medical Center
      • Voorhees Township, New Jersey, Yhdysvallat, 08043
        • MD Anderson Cancer Center at Cooper-Voorhees
      • Wayne, New Jersey, Yhdysvallat, 07470
        • Valley Medical Group - Wayne Multispecialty Practice
      • Westwood, New Jersey, Yhdysvallat, 07675
        • Valley Health System-Hematology/Oncology
    • New Mexico
      • Albuquerque, New Mexico, Yhdysvallat, 87106
        • Southwest Gynecologic Oncology Associates Inc
      • Albuquerque, New Mexico, Yhdysvallat, 87106
        • University of New Mexico Cancer Center
    • New York
      • Bay Shore, New York, Yhdysvallat, 11706
        • Northwell Health Imbert Cancer Center
      • Brightwaters, New York, Yhdysvallat, 11718
        • Island Gynecologic Oncology
      • Brooklyn, New York, Yhdysvallat, 11215
        • New York-Presbyterian/Brooklyn Methodist Hospital
      • Buffalo, New York, Yhdysvallat, 14263
        • Roswell Park Cancer Institute
      • Commack, New York, Yhdysvallat, 11725
        • Memorial Sloan Kettering Commack
      • Flushing, New York, Yhdysvallat, 11355
        • The New York Hospital Medical Center of Queens
      • Harrison, New York, Yhdysvallat, 10604
        • Memorial Sloan Kettering Westchester
      • Lake Success, New York, Yhdysvallat, 11042
        • Northwell Health/Center for Advanced Medicine
      • Mineola, New York, Yhdysvallat, 11501
        • NYU Langone Hospital - Long Island
      • New Hyde Park, New York, Yhdysvallat, 11040
        • Long Island Jewish Medical Center
      • New York, New York, Yhdysvallat, 10065
        • Memorial Sloan Kettering Cancer Center
      • New York, New York, Yhdysvallat, 10029
        • Mount Sinai Hospital
      • New York, New York, Yhdysvallat, 10032
        • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
      • New York, New York, Yhdysvallat, 10065
        • NYP/Weill Cornell Medical Center
      • New York, New York, Yhdysvallat, 10011
        • Mount Sinai Chelsea
      • New York, New York, Yhdysvallat, 10016
        • Laura and Isaac Perlmutter Cancer Center at NYU Langone
      • Rochester, New York, Yhdysvallat, 14642
        • University of Rochester
      • Rochester, New York, Yhdysvallat, 14620
        • Highland Hospital
      • Staten Island, New York, Yhdysvallat, 10305
        • Staten Island University Hospital
      • Stony Brook, New York, Yhdysvallat, 11794
        • Stony Brook University Medical Center
      • Syracuse, New York, Yhdysvallat, 13210
        • State University of New York Upstate Medical University
      • The Bronx, New York, Yhdysvallat, 10461
        • Montefiore Medical Center-Einstein Campus
      • The Bronx, New York, Yhdysvallat, 10467
        • Montefiore Medical Center - Moses Campus
      • Uniondale, New York, Yhdysvallat, 11553
        • Memorial Sloan Kettering Nassau
      • Valhalla, New York, Yhdysvallat, 10595
        • Westchester Medical Center
    • North Carolina
      • Chapel Hill, North Carolina, Yhdysvallat, 27599
        • UNC Lineberger Comprehensive Cancer Center
      • Charlotte, North Carolina, Yhdysvallat, 28203
        • Carolinas Medical Center/Levine Cancer Institute
      • Clinton, North Carolina, Yhdysvallat, 28328
        • Southeastern Medical Oncology Center-Clinton
      • Concord, North Carolina, Yhdysvallat, 28025
        • Atrium Health Cabarrus/LCI-Concord
      • Goldsboro, North Carolina, Yhdysvallat, 27534
        • Southeastern Medical Oncology Center-Goldsboro
      • Hendersonville, North Carolina, Yhdysvallat, 28791
        • Margaret R Pardee Memorial Hospital
      • Jacksonville, North Carolina, Yhdysvallat, 28546
        • Southeastern Medical Oncology Center-Jacksonville
      • Wilmington, North Carolina, Yhdysvallat, 28401
        • Novant Health New Hanover Regional Medical Center
      • Winston-Salem, North Carolina, Yhdysvallat, 27157
        • Wake Forest University Health Sciences
    • North Dakota
      • Bismarck, North Dakota, Yhdysvallat, 58501
        • Sanford Bismarck Medical Center
      • Fargo, North Dakota, Yhdysvallat, 58122
        • Sanford Roger Maris Cancer Center
      • Fargo, North Dakota, Yhdysvallat, 58122
        • Sanford Broadway Medical Center
    • Ohio
      • Akron, Ohio, Yhdysvallat, 44304
        • Summa Health System - Akron Campus
      • Beachwood, Ohio, Yhdysvallat, 44122
        • UHHS-Chagrin Highlands Medical Center
      • Canton, Ohio, Yhdysvallat, 44710
        • Aultman Health Foundation
      • Centerville, Ohio, Yhdysvallat, 45459
        • Miami Valley Hospital South
      • Chardon, Ohio, Yhdysvallat, 44024
        • Geauga Hospital
      • Cincinnati, Ohio, Yhdysvallat, 45219
        • University of Cincinnati Cancer Center-UC Medical Center
      • Cincinnati, Ohio, Yhdysvallat, 45220
        • Good Samaritan Hospital - Cincinnati
      • Cleveland, Ohio, Yhdysvallat, 44106
        • Case Western Reserve University
      • Cleveland, Ohio, Yhdysvallat, 44109
        • MetroHealth Medical Center
      • Cleveland, Ohio, Yhdysvallat, 44195
        • Cleveland Clinic Foundation
      • Cleveland, Ohio, Yhdysvallat, 44111
        • Cleveland Clinic Cancer Center/Fairview Hospital
      • Columbus, Ohio, Yhdysvallat, 43214
        • Riverside Methodist Hospital
      • Columbus, Ohio, Yhdysvallat, 43210
        • Ohio State University Comprehensive Cancer Center
      • Columbus, Ohio, Yhdysvallat, 43219
        • The Mark H Zangmeister Center
      • Mayfield Heights, Ohio, Yhdysvallat, 44124
        • Hillcrest Hospital Cancer Center
      • Mentor, Ohio, Yhdysvallat, 44060
        • UH Seidman Cancer Center at Lake Health Mentor Campus
      • Sylvania, Ohio, Yhdysvallat, 43560
        • ProMedica Flower Hospital
      • West Chester, Ohio, Yhdysvallat, 45069
        • University of Cincinnati Cancer Center-West Chester
      • Westlake, Ohio, Yhdysvallat, 44145
        • UH Seidman Cancer Center at Saint John Medical Center
    • Oklahoma
      • Oklahoma City, Oklahoma, Yhdysvallat, 73104
        • University of Oklahoma Health Sciences Center
      • Tulsa, Oklahoma, Yhdysvallat, 74146
        • Oklahoma Cancer Specialists and Research Institute-Tulsa
    • Oregon
      • Bend, Oregon, Yhdysvallat, 97701
        • Saint Charles Health System
      • Ontario, Oregon, Yhdysvallat, 97914
        • Saint Alphonsus Cancer Care Center-Ontario
      • Portland, Oregon, Yhdysvallat, 97210
        • Legacy Good Samaritan Hospital and Medical Center
      • Portland, Oregon, Yhdysvallat, 97213
        • Providence Portland Medical Center
      • Portland, Oregon, Yhdysvallat, 97225
        • Providence Saint Vincent Medical Center
      • Tualatin, Oregon, Yhdysvallat, 97062
        • Legacy Meridian Park Hospital
    • Pennsylvania
      • Allentown, Pennsylvania, Yhdysvallat, 18103
        • Lehigh Valley Hospital-Cedar Crest
      • Bethlehem, Pennsylvania, Yhdysvallat, 18017
        • Lehigh Valley Hospital - Muhlenberg
      • Danville, Pennsylvania, Yhdysvallat, 17822
        • Geisinger Medical Center
      • Ephrata, Pennsylvania, Yhdysvallat, 17522
        • Ephrata Cancer Center
      • Gettysburg, Pennsylvania, Yhdysvallat, 17325
        • Adams Cancer Center
      • Hanover, Pennsylvania, Yhdysvallat, 17331
        • WellSpan Medical Oncology and Hematology
      • Hazleton, Pennsylvania, Yhdysvallat, 18201
        • Geisinger Medical Center-Cancer Center Hazleton
      • Jefferson Hills, Pennsylvania, Yhdysvallat, 15025
        • Jefferson Hospital
      • Johnstown, Pennsylvania, Yhdysvallat, 15901
        • UPMC-Johnstown/John P. Murtha Regional Cancer Center
      • Lancaster, Pennsylvania, Yhdysvallat, 17601
        • Lancaster General Ann B Barshinger Cancer Institute
      • Lancaster, Pennsylvania, Yhdysvallat, 17602
        • Lancaster General Hospital
      • Lebanon, Pennsylvania, Yhdysvallat, 17042
        • Sechler Family Cancer Center
      • Monroeville, Pennsylvania, Yhdysvallat, 15146
        • Forbes Hospital
      • Monroeville, Pennsylvania, Yhdysvallat, 15146
        • UPMC Hillman Cancer Center - Monroeville
      • Philadelphia, Pennsylvania, Yhdysvallat, 19107
        • Thomas Jefferson University Hospital
      • Pittsburgh, Pennsylvania, Yhdysvallat, 15224
        • West Penn Hospital
      • Pittsburgh, Pennsylvania, Yhdysvallat, 15232
        • UPMC Hillman Cancer Center
      • Pittsburgh, Pennsylvania, Yhdysvallat, 15213
        • UPMC-Magee Womens Hospital
      • Pottsville, Pennsylvania, Yhdysvallat, 17901
        • Geisinger Cancer Services-Pottsville
      • Scranton, Pennsylvania, Yhdysvallat, 18510
        • Community Medical Center
      • West Reading, Pennsylvania, Yhdysvallat, 19611
        • Reading Hospital
      • Wexford, Pennsylvania, Yhdysvallat, 15090
        • Wexford Health and Wellness Pavilion
      • Wilkes-Barre, Pennsylvania, Yhdysvallat, 18711
        • Geisinger Wyoming Valley/Henry Cancer Center
      • Willow Grove, Pennsylvania, Yhdysvallat, 19090
        • Asplundh Cancer Pavilion
      • York, Pennsylvania, Yhdysvallat, 17403
        • WellSpan Health-York Cancer Center
      • York, Pennsylvania, Yhdysvallat, 17403
        • WellSpan Health-York Hospital
    • Rhode Island
      • Providence, Rhode Island, Yhdysvallat, 02905
        • Women and Infants Hospital
    • South Carolina
      • Charleston, South Carolina, Yhdysvallat, 29425
        • Medical University of South Carolina
      • Greenville, South Carolina, Yhdysvallat, 29605
        • Prisma Health Cancer Institute - Faris
      • Greenville, South Carolina, Yhdysvallat, 29607
        • Saint Francis Cancer Center
      • Greenville, South Carolina, Yhdysvallat, 29601
        • Saint Francis Hospital
      • Seneca, South Carolina, Yhdysvallat, 29672
        • Prisma Health Cancer Institute - Seneca
    • South Dakota
      • Rapid City, South Dakota, Yhdysvallat, 57701
        • Rapid City Regional Hospital
      • Sioux Falls, South Dakota, Yhdysvallat, 57105
        • Avera Cancer Institute
      • Sioux Falls, South Dakota, Yhdysvallat, 57104
        • Sanford Cancer Center Oncology Clinic
    • Tennessee
      • Memphis, Tennessee, Yhdysvallat, 38120
        • Baptist Memorial Hospital and Cancer Center-Memphis
      • Nashville, Tennessee, Yhdysvallat, 37232
        • Vanderbilt University/Ingram Cancer Center
    • Texas
      • Dallas, Texas, Yhdysvallat, 75235
        • Parkland Memorial Hospital
      • Dallas, Texas, Yhdysvallat, 75390
        • UT Southwestern/Simmons Cancer Center-Dallas
      • Houston, Texas, Yhdysvallat, 77030
        • Houston Methodist Hospital
      • Houston, Texas, Yhdysvallat, 77030
        • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
      • Houston, Texas, Yhdysvallat, 77070
        • Methodist Willowbrook Hospital
      • Houston, Texas, Yhdysvallat, 77030
        • Ben Taub General Hospital
      • Sugar Land, Texas, Yhdysvallat, 77479
        • Houston Methodist Sugar Land Hospital
      • The Woodlands, Texas, Yhdysvallat, 77385
        • Houston Methodist The Woodlands Hospital
    • Utah
      • Salt Lake City, Utah, Yhdysvallat, 84112
        • Huntsman Cancer Institute/University of Utah
      • Salt Lake City, Utah, Yhdysvallat, 84106
        • University of Utah Sugarhouse Health Center
    • Vermont
      • Burlington, Vermont, Yhdysvallat, 05401
        • University of Vermont Medical Center
    • Virginia
      • Charlottesville, Virginia, Yhdysvallat, 22908
        • University of Virginia Cancer Center
      • Richmond, Virginia, Yhdysvallat, 23298
        • VCU Massey Comprehensive Cancer Center
    • Washington
      • Gig Harbor, Washington, Yhdysvallat, 98335
        • MultiCare Gig Harbor Medical Park
      • Kennewick, Washington, Yhdysvallat, 99336
        • Kadlec Clinic Hematology and Oncology
      • Puyallup, Washington, Yhdysvallat, 98372
        • MultiCare Good Samaritan Hospital
      • Renton, Washington, Yhdysvallat, 98055
        • Valley Medical Center
      • Seattle, Washington, Yhdysvallat, 98122
        • Swedish Medical Center-First Hill
      • Tacoma, Washington, Yhdysvallat, 98405
        • MultiCare Tacoma General Hospital
      • Vancouver, Washington, Yhdysvallat, 98686
        • Legacy Salmon Creek Hospital
    • West Virginia
      • Charleston, West Virginia, Yhdysvallat, 25304
        • Vandalia Health/CAMC Institute for Academic Medicine
      • Morgantown, West Virginia, Yhdysvallat, 26506
        • West Virginia University Healthcare
      • Morgantown, West Virginia, Yhdysvallat, 26505
        • Monongalia Hospital
    • Wisconsin
      • Burlington, Wisconsin, Yhdysvallat, 53105
        • Aurora Cancer Care-Southern Lakes VLCC
      • Eau Claire, Wisconsin, Yhdysvallat, 54701
        • Marshfield Medical Center-EC Cancer Center
      • Germantown, Wisconsin, Yhdysvallat, 53022
        • Aurora Health Care Germantown Health Center
      • Grafton, Wisconsin, Yhdysvallat, 53024
        • Aurora Cancer Care-Grafton
      • Green Bay, Wisconsin, Yhdysvallat, 54311
        • Aurora BayCare Medical Center
      • Kenosha, Wisconsin, Yhdysvallat, 53142
        • Aurora Cancer Care-Kenosha South
      • Madison, Wisconsin, Yhdysvallat, 53792
        • University of Wisconsin Carbone Cancer Center - University Hospital
      • Marinette, Wisconsin, Yhdysvallat, 54143
        • Aurora Bay Area Medical Group-Marinette
      • Marshfield, Wisconsin, Yhdysvallat, 54449
        • Marshfield Medical Center-Marshfield
      • Milwaukee, Wisconsin, Yhdysvallat, 53209
        • Aurora Cancer Care-Milwaukee
      • Milwaukee, Wisconsin, Yhdysvallat, 53215
        • Aurora Saint Luke's Medical Center
      • Milwaukee, Wisconsin, Yhdysvallat, 53233
        • Aurora Sinai Medical Center
      • Minocqua, Wisconsin, Yhdysvallat, 54548
        • Marshfield Medical Center - Minocqua
      • Oconomowoc, Wisconsin, Yhdysvallat, 53066
        • ProHealth Oconomowoc Memorial Hospital
      • Oshkosh, Wisconsin, Yhdysvallat, 54904
        • Vince Lombardi Cancer Clinic - Oshkosh
      • Racine, Wisconsin, Yhdysvallat, 53406
        • Aurora Cancer Care-Racine
      • Rice Lake, Wisconsin, Yhdysvallat, 54868
        • Marshfield Medical Center-Rice Lake
      • Sheboygan, Wisconsin, Yhdysvallat, 53081
        • Vince Lombardi Cancer Clinic-Sheboygan
      • Stevens Point, Wisconsin, Yhdysvallat, 54482
        • Marshfield Medical Center-River Region at Stevens Point
      • Summit, Wisconsin, Yhdysvallat, 53066
        • Aurora Medical Center in Summit
      • Two Rivers, Wisconsin, Yhdysvallat, 54241
        • Vince Lombardi Cancer Clinic-Two Rivers
      • Waukesha, Wisconsin, Yhdysvallat, 53188
        • UW Cancer Center at ProHealth Care
      • Wauwatosa, Wisconsin, Yhdysvallat, 53226
        • Aurora Cancer Care-Milwaukee West
      • West Allis, Wisconsin, Yhdysvallat, 53227
        • Aurora West Allis Medical Center
      • Weston, Wisconsin, Yhdysvallat, 54476
        • Marshfield Medical Center - Weston

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

18 vuotta ja vanhemmat (Aikuinen, Vanhempi Aikuinen)

Hyväksyy terveitä vapaaehtoisia

Ei

Sukupuolet, jotka voivat opiskella

Nainen

Kuvaus

Inclusion Criteria:

  • Measurable stage III, measurable stage IVA, stage IVB (with or without measurable disease) or recurrent (with or without measurable disease) endometrial cancer.

  • Pathology report showing results of institutional MMR IHC testing.

  • Histologic confirmation of the original primary tumor is required (submission of pathology report(s) is required). Patients with the following histologic types are eligible: Endometrioid adenocarcinoma, serous adenocarcinoma, dedifferentiated/undifferentiated carcinoma, clear cell adenocarcinoma, mixed epithelial carcinoma, adenocarcinoma not otherwise specified (N.O.S.).

  • Submission of tumor specimens for centralized MMR IHC testing is required after Step 1 and before Step 2 registration.

  • In patients with measurable disease, lesions will be defined and monitored by RECIST version (v) 1.1. Measurable disease is defined as at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded). Each lesion must be >= 10 mm when measured by CT or magnetic resonance imaging (MRI). Lymph nodes must be >= 15 mm in short axis when measured by CT or MRI.

  • Patients may have received

    • NO prior chemotherapy for treatment of endometrial cancer OR
    • Prior adjuvant chemotherapy (e.g., paclitaxel/carboplatin alone or as a component of concurrent chemotherapy and radiation therapy [with or without cisplatin]) provided adjuvant chemotherapy was completed >= 12 months prior to STEP 2 registration.
  • Patients may have received prior radiation therapy for treatment of endometrial cancer. Prior radiation therapy may have included pelvic radiation therapy, extended field pelvic/para aortic radiation therapy, intravaginal brachytherapy, and/or palliative radiation therapy. All radiation therapy must be completed at least 4 weeks prior to STEP 2 registration.

  • Patients may have received prior hormonal therapy for treatment of endometrial cancer. All hormonal therapy must be discontinued at least three weeks prior to STEP 2 registration.

  • Interval or cytoreductive surgery, after start of treatment on this trial, and prior to documentation of disease progression, is NOT permitted.

  • Age >= 18.

  • Performance status of 0, 1 or 2.

  • Platelets >= 100,000/mcl.

  • Absolute neutrophil count (ANC) >= 1,500/mcl.

  • Creatinine =< 1.5 x institutional/laboratory upper limit of normal (ULN).

  • Total serum bilirubin level =< 1.5 x ULN (patients with known Gilbert's disease who have bilirubin level =< 3 x ULN may be enrolled).

  • Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< 3 x ULN.

  • Thyroid stimulating hormone (TSH) within normal limits. If TSH is not within normal range despite no symptoms of thyroid dysfunction, normal Free T4 level is required.

  • Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months of Step 2 registration are eligible for this trial.

  • For patients of child bearing potential: negative urine or serum pregnancy test. If the urine test is positive or cannot be confirmed as negative, a serum pregnancy test is required.

  • Administration of study drugs (pembrolizumab [MK-3475], paclitaxel, carboplatin) may have an adverse effect on pregnancy and poses a risk to the human fetus, including embryo-lethality. Women of childbearing potential (WOCBP) must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) from at least 14 days prior to Step 2 registration (for oral contraceptives), during treatment, and for 120 days after the last dose of study medication. Should a woman become pregnant or suspect she is pregnant while she is participating in this study, she should inform her treating physician immediately. Patients will be considered of nonreproductive potential if they are either:

    • Postmenopausal (defined as at least 12 months with no menses without an alternative medical cause; in women < 45 years of age, a high follicle stimulating hormone (FSH) level in the postmenopausal range may be used to confirm a postmenopausal state in women not using hormonal contraception or hormonal replacement therapy. In the absence of 12 months of amenorrhea, a single FSH measurement is insufficient); OR
    • Have a hysterectomy and/or bilateral oophorectomy, bilateral salpingectomy or bilateral tubal ligation/occlusion, at least 6 weeks prior to Step 2 registration; OR
    • Have a congenital or acquired condition that prevents childbearing.
  • Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial.

  • The patient or a legally authorized representative must provide study-specific informed consent prior to study entry and, for patients treated in the United States (U.S.), authorization permitting release of personal health information.

Exclusion Criteria:

  • Patients with prior treatment with anti-PD-1, anti-PD-L1 or anti-CTLA-4 therapeutic antibody or other similar agents.

  • Patients who have a history of a severe hypersensitivity reaction to monoclonal antibody or pembrolizumab (MK-3475) and/or its excipients; and/or a severe hypersensitivity reaction to paclitaxel and/or carboplatin.

  • Patients who are currently participating and receiving cancer-directed study therapy or have participated in a study of an investigational agent and received cancer-directed study therapy within 4 weeks prior to Step 2 registration.

  • Patients who have a diagnosis of immunodeficiency or are receiving systemic steroid therapy or any other form of immunosuppressive therapy within 7 days prior to Step 2 registration.

    • Patients who have received steroids as CT scan contrast premedication may be enrolled.
    • The use of inhaled or topical corticosteroids is allowed.
    • The use of mineralocorticoids (e.g., fludrocortisone) for patients with orthostatic hypotension or adrenocortical insufficiency is allowed.
    • The use of physiologic doses of corticosteroids may be approved after consultation with the study chair.
  • Patients with treated brain metastases are eligible if follow-up brain imaging after central nervous system (CNS)-directed therapy shows no evidence of progression, and they have been off steroids for at least 4 weeks prior to Step 2 registration and remain clinically stable.

  • Patients with active autoimmune disease or history of autoimmune disease that might recur, which may affect vital organ function or require immune suppressive treatment including systemic corticosteroids. This includes, but is not limited to, patients with a history of immune related neurologic disease, multiple sclerosis, autoimmune (demyelinating) neuropathy, Guillain-Barre syndrome, myasthenia gravis; systemic autoimmune disease such as systemic lupus erythematosus (SLE), connective tissue diseases, scleroderma, inflammatory bowel disease (IBD), Crohn's, ulcerative colitis, hepatitis; and patients with a history of toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome, or phospholipid syndrome because of the risk of recurrence or exacerbation of disease.

  • Patients with vitiligo, endocrine deficiencies including type I diabetes mellitus, thyroiditis managed with replacement hormones including physiologic corticosteroids are eligible.

  • Patients with rheumatoid arthritis and other arthropathies, Sjogren's syndrome and psoriasis controlled with topical medication and patients with positive serology, such as antinuclear antibodies (ANA), anti-thyroid antibodies should be evaluated for the presence of target organ involvement and potential need for systemic treatment but should otherwise be eligible.

  • Patients who have a history of (non-infectious) pneumonitis that required steroids, or current pneumonitis.

  • Uncontrolled intercurrent illness including, but not limited to: ongoing or active infection (except for uncomplicated urinary tract infection), interstitial lung disease or active, non-infectious pneumonitis, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.

  • Known clinically significant liver disease, including active viral, alcoholic, or other hepatitis; and cirrhosis.

    • For patients with evidence of chronic hepatitis B virus (HBV) infection, the HBV viral load must be undetectable on suppressive therapy, if indicated.
    • Patients with a history of hepatitis C virus (HCV) infection must have been treated and cured. For patients with HCV infection who are currently on treatment, they are eligible if they have an undetectable HCV viral load.
  • Pregnant or lactating patients.

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Hoito
  • Jako: Satunnaistettu
  • Inventiomalli: Rinnakkaistehtävä
  • Naamiointi: Nelinkertaistaa

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Active Comparator: Arm I (placebo, paclitaxel, carboplatin)

COMBINATION PHASE: Patients receive placebo IV over 30 minutes on day 1 of each cycle, paclitaxel IV over 3 hours on day 1 of each cycle, and carboplatin IV over 30-60 minutes on day 1 of each cycle. Treatment repeats every 3 weeks for 6 cycles in the absence of disease progression or unacceptable toxicity. Patients with SD or PR who still have measurable disease may continue treatment for up to a total of 10 cycles (if deemed necessary by the treating physician) in the absence of disease progression or unacceptable toxicity.

MAINTENANCE PHASE: Patients receive placebo IV over 30 minutes on day 1 of each cycle. Treatment repeats every 6 weeks for up to 14 cycles in the absence of disease progression or unacceptable toxicity.

Patients undergo CT scan throughout the study.

On February 6, 2023, all patient treatment assignments were unblinded. Patients randomized to Arm 1 will not receive additional placebo infusions.

Given IV

Muut nimet:
  • Blastocarb
  • Carboplat
  • Carboplatin Hexal
  • Carboplatino
  • Karboplatina
  • Karbosiini
  • Carbosol
  • Carbotec
  • CBDCA
  • Displata
  • Ercar
  • JM-8
  • Nealorin
  • Novoplatina
  • Paraplatiini
  • Paraplatin AQ
  • Platina oli
  • Ribocarbo
  • JM8

Given IV

Muut nimet:
  • Taxol
  • Anzatax
  • Asotax
  • Bristaxol
  • Praxel
  • Taxol Konzentrat

Ancillary studies

Muut nimet:
  • Elämänlaadun arviointi

Given IV

Ancillary studies

Undergo CT scan

Muut nimet:
  • CT
  • KISSA
  • Kerroskuvaus
  • Aksiaalinen tietokonetomografia
  • Tietokoneistettu aksiaalinen tomografia
  • Tietokonetomografia
  • tomografia
  • Tietokoneistettu aksiaalinen tomografia (menettely)
  • Tietokonetomografia (CT).
  • Diagnostinen CAT -skannaus
  • Diagnostinen kissan skannauspalvelutyyppi
Kokeellinen: Arm II (pembrolizumab, paclitaxel, carboplatin)

COMBINATION PHASE: Patients receive pembrolizumab IV over 30 minutes on day 1 of each cycle, paclitaxel IV over 3 hours on day 1 of each cycle, and carboplatin IV over 30 minutes on day 1 of each cycle. Treatment repeats every 3 weeks for 6 cycles in the absence of disease progression or unacceptable toxicity. Patients with SD or PR who still have measurable disease may continue treatment for up to a total of 10 cycles (if deemed necessary by the treating physician) in the absence of disease progression or unacceptable toxicity.

MAINTENANCE PHASE: Patients receive pembrolizumab IV over 30-60 minutes on day 1 of each cycle. Treatment repeats every 6 weeks for up to 14 cycles in the absence of disease progression or unacceptable toxicity.

Patients undergo CT scan throughout the study.

Given IV

Muut nimet:
  • Blastocarb
  • Carboplat
  • Carboplatin Hexal
  • Carboplatino
  • Karboplatina
  • Karbosiini
  • Carbosol
  • Carbotec
  • CBDCA
  • Displata
  • Ercar
  • JM-8
  • Nealorin
  • Novoplatina
  • Paraplatiini
  • Paraplatin AQ
  • Platina oli
  • Ribocarbo
  • JM8

Given IV

Muut nimet:
  • Taxol
  • Anzatax
  • Asotax
  • Bristaxol
  • Praxel
  • Taxol Konzentrat

Ancillary studies

Muut nimet:
  • Elämänlaadun arviointi

Ancillary studies

Given IV

Muut nimet:
  • Keytruda
  • MK-3475
  • Lambrolitsumabi
  • SCH 900475
  • MK3475
  • SCH-900475
  • BCD-201
  • Pembrolitsumabi biosimilar BCD-201
  • Pembrolitsumabi biosimilar QL2107
  • QL2107
  • GME 751
  • GME751
  • Pembrolitsumabi biosimilar GME751
  • MK 3475
  • SCH900475
  • Pembrolitsumabi, biologisesti samanlainen RPH-075
  • RPH 075
  • RPH-075
  • RPH075
  • Pembrolitsumabi Biosimilar SB27
  • SB 27
  • SB-27
  • SB27

Undergo CT scan

Muut nimet:
  • CT
  • KISSA
  • Kerroskuvaus
  • Aksiaalinen tietokonetomografia
  • Tietokoneistettu aksiaalinen tomografia
  • Tietokonetomografia
  • tomografia
  • Tietokoneistettu aksiaalinen tomografia (menettely)
  • Tietokonetomografia (CT).
  • Diagnostinen CAT -skannaus
  • Diagnostinen kissan skannauspalvelutyyppi

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Progression-free Survival (PFS)
Aikaikkuna: Duration of time from study entry to time of progression per RECIST criteria or death due to any cause, whichever occurs first. The interquartile range for follow-up was (6.37 months, 30.62 months). The maximum for follow-up was 37.85 months.

Progression free survival (PFS) Note: For arm 2 (dMMR Cohort), the point estimate and the upper limit of the confidence interval are not able to be estimated due to insufficient events.

Duration of time from study entry to time of progression per RECIST criteria or death due to any cause, whichever occurs first. The interquartile range for follow-up was (6.37 months, 30.62 months). The maximum for follow-up was 37.85 months.

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Adverse Events With Grade 3 (or Higher)
Aikaikkuna: For the adverse event time frame, the interquartile range was (0.79 months, 3.42 months); the maximum was 28.39 months.

Assessed by Common Terminology Criteria for Adverse Events (CTCAE V5.0). The endpoint is the count of participants with an adverse event of grade 3 (or higher) by treatment group.

For the adverse event time frame, the interquartile range was (0.79 months, 3.42 months); the maximum was 28.39 months.
Objective Tumor Response
Aikaikkuna: For the time frame for tumor response, the interquartile range was (2.27 months, 8.66 months) and the maximum was 36.37 months.

Assessed by Response Evaluation Criteria for Solid Tumors (RECIST) 1.1.

For the time frame for tumor response, the interquartile range was (2.27 months, 8.66 months) and the maximum was 36.37 months.
Duration of Objective Response
Aikaikkuna: For the duration of objective response, the interquartile range is (4.24 months, 7.92 months); the maximum is 28.68 months.

The time difference between the dates of first response and first progression; patients who do not progress are considered censored. Note: for Arm 2 (dMMR Cohort), the upper limit of the confidence interval is not able to be estimated due to an insufficient number of events.

For the duration of objective response, the interquartile range is (4.24 months, 7.92 months); the maximum is 28.68 months.
Overall Survival (OS)
Aikaikkuna: Time from study entry to time of death or the date of last contact, assessed up to 5 years

Overall Survival (OS). This endpoint will be assessed by Kaplan-Meier.

Time from study entry to time of death or the date of last contact, assessed up to 5 years
Quality of Life (QoL) in pMMR Patients Only
Aikaikkuna: 0-54 weeks from start of treatment

QoL are collected in pMMR patients only and measured with the Function Assessment of Cancer Therapy -Endometrial Trial Outcome Index (FACT En-TOI). The FACT-En TOI scores range 0 - 120 with a larger score suggesting better or favorable state of QOL.

0-54 weeks from start of treatment
Concordance Between Institutional Mismatch Repair (MMR) Immunohistochemistry (IHC) Testing and Centralized MMR IHC
Aikaikkuna: IHC testing values (for both central and institutional) were collected at baseline.

Concordance between institutional MMR IHC testing and centralized MMR IHC. The concordance of institutional MMR IHC testing and centralized MMR IHC will be characterized by agreement statistics including the kappa statistic (e.g. Cohen's kappa coefficient).

IHC testing values (for both central and institutional) were collected at baseline.

Muut tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Incidence of Pembrolizumab Treatment and Self-reported Neurotoxicity
Aikaikkuna: 0-54 weeks from start of treatment

Patient-reported neurotoxicity will be measured with FACT/GOG-Ntx subscale (short form).

0-54 weeks from start of treatment
Effect of Pembrolizumab on PFS and OS by Program Death Ligand 1 (PD-L1) IHC
Aikaikkuna: 5 years

Will assess the effect of pembrolizumab on PFS and OS by PD-L1 (combined positive score [CPS]) within proficient MMR (pMMR) and deficient MMR (dMMR) populations. The effectiveness of pembrolizumab will be compared by PD-L1 status (CPS). A formal test will be conducted by examining the interaction term between pembrolizumab treatment (yes or no) with PD-L1 status. The association between PD-L1 CPS status and MMR IHC status will be assessed with odds ratios. A test may be conducted with a Fisher's Exact Test, and confidence intervals will be provided.

5 years
Association Between PD-L1 IHC and MMR Status
Aikaikkuna: 5 years

Measures of association between PD-L1 IHC (CPS) and MMR IHC status. The concordance of institutional MMR IHC testing and centralized MMR IHC will be characterized by agreement statistics such as kappa statistics (e.g. Cohen's kappa coefficient).

5 years

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Tutkijat

  • Päätutkija: Ramez N Eskander, NRG Oncology

Julkaisuja ja hyödyllisiä linkkejä

Tutkimusta koskevien tietojen syöttämisestä vastaava henkilö toimittaa nämä julkaisut vapaaehtoisesti. Nämä voivat koskea mitä tahansa tutkimukseen liittyvää.

Yleiset julkaisut

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Todellinen)

Torstai 22. elokuuta 2019

Ensisijainen valmistuminen (Todellinen)

Perjantai 16. joulukuuta 2022

Opintojen valmistuminen (Arvioitu)

Sunnuntai 26. syyskuuta 2027

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Perjantai 12. huhtikuuta 2019

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Perjantai 12. huhtikuuta 2019

Ensimmäinen Lähetetty (Todellinen)

Tiistai 16. huhtikuuta 2019

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Perjantai 13. marraskuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Keskiviikko 11. marraskuuta 2026

Viimeksi vahvistettu

Tiistai 1. syyskuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Yksittäisten osallistujien tietojen suunnitelma (IPD)

Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?

JOO

IPD-suunnitelman kuvaus

NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Joo

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Yhdysvalloissa valmistettu ja sieltä viety tuote

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa